RIPK2

Chr 8

receptor interacting serine/threonine kinase 2

Also known as: CARD3, CARDIAK, CCK, GIG30, RICK, RIP2

This gene encodes a serine/threonine protein kinase that serves as a key effector in NOD1 and NOD2 innate immune signaling pathways, functioning as a scaffolding protein that activates NF-kappa-B transcription and immune responses to bacterial peptidoglycans. Mutations cause early-onset inflammatory bowel disease and immunodeficiency, following an autosomal recessive inheritance pattern. The gene shows high constraint against loss-of-function variants (LOEUF 0.441), indicating that complete loss of protein function is likely deleterious.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
55
Pubs (1 yr)
33
P/LP submissions
0%
P/LP missense
0.44
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryRIPK2
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.22) despite low pLI — interpret in context.
📋
ClinVar Variants
33 unique Pathogenic / Likely Pathogenic· 54 VUS of 117 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.44LOEUF
pLI 0.393
Z-score 3.73
OE 0.22 (0.120.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
2.16Z-score
OE missense 0.63 (0.560.72)
172 obs / 272.2 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.22 (0.120.44)
00.351.4
Missense OE0.63 (0.560.72)
00.61.4
Synonymous OE0.84
01.21.6
LoF obs/exp: 6 / 26.8Missense obs/exp: 172 / 272.2Syn Z: 1.20
DN
0.6261th %ile
GOF
0.80top 10%
LOF
0.3647th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

117 submitted variants in ClinVar

Classification Summary

Pathogenic33
VUS54
Likely Benign5
Benign4
33
Pathogenic
54
VUS
5
Likely Benign
4
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
33
0
33
Likely Pathogenic
0
0
0
0
0
VUS
0
46
8
0
54
Likely Benign
0
4
0
1
5
Benign
0
1
2
1
4
Total05143296

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RIPK2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →